Edgewise Therapeutics · 2 weeks ago
Senior Manager/Associate Director, Clinical Operations (EDG-2026002)
Edgewise Therapeutics is dedicated to discovering new medicines for patients with serious muscle diseases. The Senior Manager/Associate Director of Clinical Operations will provide operational expertise and strategic input for clinical trials, overseeing budgets, timelines, and vendor management to ensure successful study execution.
BiopharmaBiotechnologyHealth Care
Responsibilities
Provide operational expertise and strategic input for assigned clinical trials
Provide expertise and operational input into protocol synopsis, final protocol, Informed Consent and other study related documents
Independently creates and manages budgets, forecasting, and monitoring for assigned studies
Oversee country and site feasibility/selection process, with a focus on providing country insights, corporate agreement, and therapeutic expertise to ensure understanding between study execution plan and program strategy
Provide strategic input and management of site activation activities and recruitment strategies
Oversight of study timelines to ensure the needs of the clinical development plan are met
Oversee strategic partners/CRO/vendor selection, budget and contract negotiation, and proper guidance of performance for all activities assigned to a strategic partner/CRO/vendor for assigned studies, including escalation of issues to governance committees when warranted
Approval of essential monitoring documents/plans, periodic review of outputs and actions related to monitoring
Study team meeting management and attendance; regular review of meeting agendas and minutes
Review outcomes/actions related to protocol deviations review; primary purpose of review is to help identify trends across sites or the study
Identify, monitor and review operational risks and decisions at the study level and implementation of mitigation strategies. Oversee site KPIs, protocol deviations and metrics to identify trends and maintain data quality. Escalate site level risks or non-compliance, and in collaboration with Quality Assurance, review Site Corrective and Action Plans (SCAPAs), Corrective and Action Plans (CAPAs) and Site Audits
Maintains cross-functional partnership to test all database timelines and plans; ensure linkage between the strategy (i.e., filing/registration, data generation) with the tactical plan for database lock and CSR
Contributes to drafting Standard Operating Procedures (SOPs) and adheres to Clinical Operations processes and SOPs to ensure studies are "inspection ready" at all times; may be involved in regulatory inspections by preparing for and attending the inspections
Support onboarding, mentor and manage direct reports within the department
May collaborate with other functional leads to manage project related efforts. Participates in departmental quality or process improvement initiatives
Read, understand, and comply with all workplace health and safety policies; safe work practices; and company policies and procedures
Perform other duties as assigned by supervisor
Qualification
Required
Bachelor's Degree (Life Sciences)
At least 8+ years of relevant clinical operations experience in clinical trial design and conduct, with minimum of 6 years at a biotech or pharmaceutical company
Experience must include Phase 2 and 3 studies (globally recruited)
In-depth knowledge of clinical research operations, including GCP, FDA and/or EMEA regulations, and ICH guidelines
Excellence in project management and communication
Preferred
Experience in more than one therapeutic area is advantageous
Pediatric experience is a plus
Experience working with various CRO partnership models, including FSP, and full-service arrangements is preferred
Benefits
Health benefits
Discretionary bonus plan
Stock option grants
Stock purchase plan
401(k) with match
Paid time off
Company
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Funding
Current Stage
Public CompanyTotal Funding
$738.5MKey Investors
Viking Global Investors
2025-04-02Post Ipo Equity· $200M
2024-01-19Post Ipo Equity· $240M
2022-09-13Post Ipo Equity· $138M
Leadership Team
Recent News
MarketScreener
2025-12-25
MarketScreener
2025-12-25
Company data provided by crunchbase